OPPM
Opus Point Partners Management Portfolio holdings
AUM
$46.9M
This Quarter Return
-1.31%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$58.3M
AUM Growth
+$58.3M
(-9.3%)
Cap. Flow
-$3.29M
Cap. Flow
% of AUM
-5.64%
Top 10 Holdings %
Top 10 Hldgs %
53.36%
Holding
75
New
1
Increased
16
Reduced
1
Closed
13
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$319K |
| 2 |
Exact Sciences
EXAS
|
$288K |
| 3 |
Biogen
BIIB
|
$263K |
| 4 |
Nektar Therapeutics
NKTR
|
$78.2K |
| 5 |
Ligand Pharmaceuticals
LGND
|
$41.8K |
Top Sells
| 1 |
Regenxbio
RGNX
|
$506K |
| 2 |
CLLS
Cellectis
CLLS
|
$409K |
| 3 |
Supernus Pharmaceuticals
SUPN
|
$408K |
| 4 |
RUBY
Rubius Therapeutics, Inc
RUBY
|
$391K |
| 5 |
Wave Life Sciences
WVE
|
$377K |
Sector Composition
| 1 | Healthcare | 64.95% |
